Back to Search Start Over

Cognitive behavioral therapy for insomnia to reduce cannabis use: Results from a pilot randomized controlled trial.

Authors :
Todd Arnedt, J.
Conroy, Deirdre A.
Stewart, Haylie
Yeagley, Emily
Bowyer, Gabrielle
Bohnert, Kipling M.
Ilgen, Mark A.
Source :
Drug & Alcohol Dependence. May2023, Vol. 246, pN.PAG-N.PAG. 1p.
Publication Year :
2023

Abstract

Individuals with regular cannabis use demonstrate adverse health outcomes, yet infrequently seek treatment. Insomnia, a common co-occurring complaint, could be targeted to reduce cannabis use and improve functioning in these individuals. In an intervention development study, we refined and tested the preliminary efficacy of a telemedicine-delivered CBT for insomnia tailored to individuals with regular cannabis use for sleep (CBTi-CB-TM). In this single-blind randomized trial, fifty-seven adults (43 women, mean age 37.6 ± 12.8 years) with chronic insomnia and cannabis use for sleep ≥3 times/week received CBTi-CB-TM (n = 30) or sleep hygiene education (SHE-TM, n = 27). Participants completed self-reported assessments of insomnia (Insomnia Severity Index [ISI]) and cannabis use (Timeline Followback [TLFB] and daily diary data) at pre-treatment, post-treatment, and 8-week follow-up. ISI scores improved significantly more in the CBTi-CB-TM compared to SHE-TM condition (β = −2.83, se=0.84, P = 0.004, d=0.81). At 8-week follow-up, 18/30 (60.0 %) CBTi-CB-TM compared to 4/27 (14.8 %) SHE-TM participants were in remission from insomnia (X2 =12.8, P = 0.0003). The TLFB showed a small reduction in past 30-day cannabis use for both conditions (β = −0.10, se=0.05, P = 0.026); CBTi-CB-TM participants demonstrated greater post-treatment reductions in the % of days cannabis was used within 2 h of bedtime (−29.1 ± 7.9 % fewer days vs. 2.6 ± 8.0 % more days, P = 0.008). CBTi-CB-TM is feasible, acceptable, and demonstrated preliminary efficacy for improving sleep and cannabis-related outcomes among non-treatment-seeking individuals with regular cannabis use for sleep. Although sample characteristics limit generalizability, these findings support the need for adequately powered randomized controlled trials with longer follow-up periods. • Individuals who regularly use cannabis for sleep frequently have insomnia. • CBT for insomnia is feasible and acceptable in those who use cannabis for sleep. • CBT for insomnia may improve insomnia and reduce cannabis use before bedtime. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03768716
Volume :
246
Database :
Academic Search Index
Journal :
Drug & Alcohol Dependence
Publication Type :
Academic Journal
Accession number :
163185792
Full Text :
https://doi.org/10.1016/j.drugalcdep.2023.109835